Tesla: Topline Hurt By EV Demand Stagnation

Summary:

  • Tesla faces significant challenges, including declining market share in China and stagnating EV adoption in Europe and the United States, leading to a bearish outlook.
  • The stock appears overpriced based on both DCF and historical valuation metrics, suggesting a potential downside of nearly 33%.
  • Potential delays in regulatory approval for Tesla’s Robotaxis and economic uncertainties further dampen short-term growth prospects, reinforcing my Sell rating.
  • GARP investors should look to buy around the $150 level, as was seen in April 2024.

Editor’s note: Seeking Alpha is proud to welcome Shubhm Mitessh Thakkar as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.

A car made of leaves with an exhaust trail of leaves

Richard Drury


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I am a trader, so I may take long/short positions across stocks or indices based on trading signals. I want to disclose that I do not have any position in Tesla (stock, option or other derivatives), nor do intend to do so in the next 72 hours. However, I may take trading positions in Indices that Tesla is a part of – S&P 500 and NASDAQ 100.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *